Vascular Interventions in Oncology.

Vascular interventions are an important and established tool in the management of the oncology patient. The goal of these procedures may be curative, palliative or adjunctive in nature. Some of the common vascular interventions used in oncology include transarterial embolisation or chemoembolisation, selective internal radiation therapy, chemosaturation, venous access lines, superior vena cava stenting and portal vein embolisation.

Uterine artery embolisation: fertility, adenomyosis and size - what is the evidence?

Background: Uterine artery embolisation is well established as a treatment for symptomatic fibroids, however, there remain some uncertainties. We have carried out a focused literature review on three particularly challenging aspects - post-procedure fertility, symptomatic adenomyosis and large volume fibroids and uteri, to enable operators to utilise evidence-based guidance in patient selection, consent, and management.

Review: Literature searches were performed of the PubMed/Medline, Google scholar, EMBASE and Cochrane databases.

Huge Chiari Network in the Right Atrium Diagnosed as Thrombosis - Case Report and a Brief Review.

The Chiari network is a common benign finding usually found incidentally in the right atrium (RA). This lesion frequently coexists with patent foramen ovale (PFO). Although the Chiari network is diagnosed easily and has no clinical importance, sometimes, the accurate diagnosis becomes hard and the lesion itself, or with PFO, can lead to clinical events.

Randomised Controlled Trial of Particles Used in Uterine fibRoid Embolisation (PURE): Non-Spherical Polyvinyl Alcohol Versus Calibrated Microspheres.

Purpose: The PURE study is a randomised controlled trial (RCT) comparing the clinical and MRI outcomes of patients treated with non-spherical polyvinyl alcohol, ns-PVA (Contour PVA-Boston Scientific-355-500 & 500-700 microns) versus calibrated hydrogel microspheres (Embozene-Varian Inc-700 & 900 microns) for symptomatic uterine fibroids.

Materials And Methods: Prospective, ethically approved non-sponsored RCT in 84 patients in a single UK tertiary IR unit, ISRCTN registry trial number ISRCTN18191539 in 2013 and 2014. All patients with symptomatic fibroid disease were eligible.

Delayed ileal-ileocystoplasty fistula formation: an unusual complication of augmentation enterocystoplasty.

Augmentation enterocystoplasty is a successful treatment for patients with neurogenic bladder dysfunction. Delayed spontaneous bladder rupture is a serious recognised complication of the procedure; however, to our knowledge, delayed fistula formation between the neobladder and the gastrointestinal tract has not been reported in the literature. We report the case of a 21-year-old male who presented with chronic diarrhoea resulting from an ileal-ileocystoplasty fistula 10 years following a successful augmentation enterocystoplasty.